SpineSmith to rollout VisuALIF stand alone device for intervertebral body fusion of lumbar spine

NewsGuard 100/100 Score

SpineSmith, a Texas-based medical device company, today announces the company will begin the national rollout in March of the VisuALIF, following a successful Alpha launch.  

The VisuALIF is a two-piece, stand alone device indicated for intervertebral body fusion of the lumbar spine that received FDA clearance for commercial sale in the United States in October 2010.   VisuALIF is the first modular lumbar interbody device with an open-face allowing in situ graft placement, tactile feedback with face plate attachment and device placement flush with the anterior aspect of the vertebrae.  The device is available in a range of product sizes and configurations designed to meet surgeon requirements across a wide spectrum of patient anatomy.

Brian Burkinshaw, SpineSmith's Vice President of Engineering, believes the VisuALIF offers a unique solution for surgeons.  "The VisuALIF incorporates an anterior open-face, allowing surgeons to visualize end plate preparation post-placement, leading to optimum graft placement with respect to larger available volumes.  During our alpha launch we received positive feedback regarding the implant and have fine-tuned our instrumentation to create a best in class system relative to surgeon ease of use."

Chuck Reynolds, Vice President of Sales, and his team are currently expanding the company's sales distribution network, while enhancing the new product training program on the strength of the alpha launch feedback. Mr. Reynolds states; "We are continuing to build momentum for the VisuALIF by enlarging the national sales distribution network while working with premier spine surgeons and institutions during the national roll out."

Source:

SpineSmith Partners LP

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The effects of high maternal folate intake on the health outcomes of offspring